cyclosporine has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (20.00) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Arava, S; Baskaran, N; Gupta, S; Mehta, N | 1 |
Bennett, C; Chen, S; Hannon, CW; Lima, HC; McCourt, C | 1 |
Banovic, F; Linek, M; Olivry, T; Robson, D | 1 |
Banovic, F; Linder, KE; Olivry, T; Tobias, JR | 1 |
Brown, DC; Casal, ML; Mauldin, EA; Morris, DO | 1 |
Bonsmann, G; Kuhn, A; Ruland, V | 1 |
Fleck, M; Klein, A; Landthaler, M; Vogt, T; Wenzel, SM | 1 |
Abuchar, A; Dehesa, L; Kerdel, FA; Nuno-Gonzalez, A; Vitiello, M | 1 |
Christofidou, E; Doulaveri, G; Giannadaki, M; Kontochristopoulos, GJ; Zakopoulou, N | 1 |
Heath, M; Raugi, GJ | 1 |
Bardagi, M; Fondevila, D; Font, A; Mascort, J | 1 |
Grabbe, S; Kolde, G | 1 |
Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K | 1 |
Bambauer, R; Schiel, R | 1 |
de la Mata, J; Fernández-Espartero, MC; Rodríguez, M; Satué, JA | 1 |
4 review(s) available for cyclosporine and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
Interventions for cutaneous disease in systemic lupus erythematosus.
Topics: Age of Onset; Azathioprine; Bias; Biological Factors; Chloroquine; Cosmetic Techniques; Cyclosporine; Dermatologic Agents; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methotrexate; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Skin Diseases; Symptom Flare Up | 2021 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
The use of cyclosporine in dermatology.
Topics: Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatomyositis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Prurigo; Psoriasis; Pyoderma Gangrenosum; Skin Diseases; Sweet Syndrome; Urticaria | 2012 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
1 trial(s) available for cyclosporine and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.
Topics: Adalimumab; Animals; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cyclosporine; Dog Diseases; Dogs; Fatty Acids; Female; Genetic Predisposition to Disease; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male | 2010 |
10 other study(ies) available for cyclosporine and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
B cell depletion therapy using rituximab to induce long-term remission of recalcitrant skin lesions of subacute cutaneous lupus erythematosus.
Topics: Chilblains; Cyclosporine; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Rituximab | 2022 |
Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Calcineurin Inhibitors; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Lupus Erythematosus, Cutaneous; Male; Skin; Tacrolimus; Treatment Outcome | 2017 |
Pathology in practice. Psoriasiform lichenoid dermatitis.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dog Diseases; Dogs; Drug Eruptions; Drug Therapy, Combination; Female; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Prednisolone | 2014 |
Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus.
Topics: Adult; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Cutaneous; Methotrexate; Middle Aged; Treatment Outcome | 2011 |
Psoriasis coexisting with subacute cutaneous lupus erythematosus.
Topics: Biopsy, Needle; Cyclosporine; Female; Follow-Up Studies; Humans; Immunohistochemistry; Lupus Erythematosus, Cutaneous; Middle Aged; Psoriasis; Risk Assessment; Treatment Outcome | 2004 |
Treatment with oral cyclosporin A of a case of vesicular cutaneous lupus erythematosus in a rough collie.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Dog Diseases; Dogs; Lupus Erythematosus, Cutaneous; Male | 2006 |
Coexisting lichen planus and subacute cutaneous lupus erythematosus.
Topics: Aged; Aged, 80 and over; Cyclosporine; Female; Humans; Lichen Planus; Lupus Erythematosus, Cutaneous | 1995 |
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3; Complement System Proteins; Cyclosporine; Dapsone; Dermatologic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Prednisolone; Pruritus; Skin Diseases, Papulosquamous | 1996 |
Therapeutic plasma exchange and cyclosporine in the treatment of systemic lupus erythematosus.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Plasma Exchange; Treatment Outcome | 1999 |
[Blistering cutaneous lesions in a patient with systemic lupus erythematosis].
Topics: Adult; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Stevens-Johnson Syndrome | 2001 |